3 news items
Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression
NMRA
14 May 24
mission is to redefine neuroscience drug development by bringing forward the next generation of novel therapies that offer improved treatment outcomes
Neumora Therapeutics to Participate in Upcoming Conferences in May
NMRA
6 May 24
. Neumora's mission is to redefine neuroscience drug development by bringing forward the next generation of novel therapies that offer improved treatment
Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study
NMRA
15 Apr 24
portfolio as we seek to fulfill our mission to develop medicines for serious brain diseases. We anticipate several important milestones including Phase 3
- Prev
- 1
- Next